Evogene Ltd
EVGN1.380USD
-0.140-9.21%
Handelsschluss 06/13, 16:00（ET）Kurse um 15 Minuten verzögert
9.21MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Evogene Ltd Unternehmen
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Unternehmensinformationen
BörsenkürzelEVGN
Name des UnternehmensEvogene Ltd
IPO-datumJun 11, 2007
Gegründet am1999
CEODr. Arnon Heyman
Anzahl der mitarbeiter117
WertpapierartOrdinary Share
GeschäftsjahresendeJun 11
Addresse13 Gad Feinstein Street
StadtREHOVOT
BörseNASDAQ Capital Market Consolidated
LandIsrael
Postleitzahl7638517
Telefon97289311900
Websitehttps://evogene.com/
BörsenkürzelEVGN
IPO-datumJun 11, 2007
Gegründet am1999
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Dr. Adrian Percy
Dr. Adrian Percy
Independent Director
Independent Director
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Kenny Green
Kenny Green
Investor Relations
Investor Relations
--
--
Ms. Dorit Kreiner
Ms. Dorit Kreiner
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Dan Michael Falk
Mr. Dan Michael Falk
Independent Director
Independent Director
--
--
Dr. Brian Ember
Dr. Brian Ember
Chief Executive Officer of AgPlenus Limited
Chief Executive Officer of AgPlenus Limited
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Dr. Adrian Percy
Dr. Adrian Percy
Independent Director
Independent Director
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Apr 6
Währung: USDAktualisiert: Sun, Apr 6
FY2024
FY2018
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
Other
4.00M
47.00%
United States
3.92M
46.00%
Israel
595.77K
7.00%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Sat, May 17
Aktualisiert: Sat, May 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Armistice Capital LLC
4.74%
Recanati (Leon Yehuda)
1.26%
Jane Street Capital, L.L.C.
0.51%
UBS Financial Services, Inc.
0.28%
Morgan Stanley & Co. LLC
0.22%
Other
93.00%
Aktionäre
Aktionäre
Anteil
Armistice Capital LLC
4.74%
Recanati (Leon Yehuda)
1.26%
Jane Street Capital, L.L.C.
0.51%
UBS Financial Services, Inc.
0.28%
Morgan Stanley & Co. LLC
0.22%
Other
93.00%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
4.94%
Individual Investor
1.26%
Research Firm
0.93%
Investment Advisor
0.44%
Venture Capital
0.15%
Investment Advisor/Hedge Fund
0.06%
Other
92.22%
Institutionelle Beteiligung
Aktualisiert: Mon, Feb 24
Aktualisiert: Mon, Feb 24
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
54
511.12K
7.85%
-247.01K
2024Q4
56
495.82K
9.24%
-272.31K
2024Q3
56
646.41K
12.68%
+45.84K
2024Q2
57
498.30K
80.86%
-140.56K
2024Q1
62
510.64K
10.05%
-122.17K
2023Q4
69
544.86K
11.19%
-474.65K
2023Q3
76
590.60K
14.30%
-53.35K
2023Q2
75
185.66K
4.46%
-461.57K
2023Q1
80
194.62K
4.68%
-499.69K
2022Q4
84
224.28K
5.44%
-1.02M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Armistice Capital LLC
298.28K
5.56%
+103.59K
+53.21%
Dec 31, 2024
Recanati (Leon Yehuda)
83.89K
1.56%
--
--
Mar 17, 2024
Jane Street Capital, L.L.C.
21.34K
0.4%
+21.34K
--
Dec 31, 2024
UBS Financial Services, Inc.
22.01K
0.41%
+13.41K
+155.92%
Dec 31, 2024
Morgan Stanley & Co. LLC
14.56K
0.27%
+1.98K
+15.74%
Dec 31, 2024
Two Sigma Investments, LP
11.16K
0.21%
+11.16K
--
Dec 31, 2024
BNP Paribas Securities Corp. North America
12.82K
0.24%
+619.00
+5.07%
Dec 31, 2024
P&S Vermögensberatungs AG Performance & Sicherheit
10.00K
0.19%
--
--
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Aug 03, 2022
Merger
10<1
Aug 03, 2022
Merger
10<1
Aug 03, 2022
Merger
10<1
Datum
Art
Verhältnis
Aug 03, 2022
Merger
10<1
Aug 03, 2022
Merger
10<1
Aug 03, 2022
Merger
10<1
